Aprea Therapeutics, Inc.
- APRE
- NASDAQ
- Biotechnology
- Cancer Therapeutics (DNA Repair)
- Oral ATR Inhibitor
$0.53
Today −8.88%Quote Oct 19, 2026, 08:00 PM UTC
−29.95%over the last month
Max drawdown −31.8%From 1-month high −31.8%3 months −18.4%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Aprea Therapeutics
Aprea Therapeutics, Inc. is a biopharmaceutical company in its clinical development stage, dedicated to discovering and marketing innovative cancer treatments. Their therapeutic approach centers on modulating DNA damage response pathways.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
8
Market value
$6.7M
Quote Oct 19
Floor
$0.52
2.3% below price
Resistance
$0.55
3.7% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about APREPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free